Saturday, October 3, 2026

USD/EUR Bearish Momentum With A 2% Fall In The Last 21 Sessions

ViaNews Editorial Team

August 21, 2024

USD/EUR Bearish Momentum With A 2% Fall In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.4% for the last 21 sessions. At 08:08 EST on Wednesday, 21 August, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 0.178% up from its 52-week low and 6.029% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.26%, a negative 0.12%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.40% (last week), 0.28% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd: FX options markets suggest some active buying – ING. According to FXStreet on Tuesday, 20 August, "The one-month risk reversal -the price of a EUR/USD call option over an equivalent put option -is moving deeper in favour of euro calls. ", "1.1040/1050 should prove intra-day support for EUR/USD and we see the 1.1110/1140 as big medium-term resistance - a break of which would be big news."
  • Eur/usd: A run towards 1.1 near term is possible – scotiabank. According to FXStreet on Tuesday, 20 August, "The Euro (EUR) is showing a marginal loss on the day on the screens but EUR/USD has essentially moved sideways in a narrow range overnight as the market consolidates around the EUR's highest point since the start of the year, Scotiabank's Chief FX Strategist Shaun Osborne notes.", "While much attention falls on the Fed policy outlook as a driver of EUR/USD gains, the ECB cannot be overlooked. "
  • Eur/usd: new range? – rabobank. According to FXStreet on Tuesday, 20 August, "As we argued earlier this month, we see upside risks for EUR/USD as likely to be associated with a softer USD rather than a broadly stronger EUR. ", "On balance, while we can not rule out another dip to the EUR/USD1.08 area in the weeks ahead, we expect EUR/USD to 1.09/1.10 area to become more comfortable for EUR/USD in the coming months."
  • Eur/usd holds below 1.1150 amid cautious mood, all eyes on FOMC minutes. According to FXStreet on Wednesday, 21 August, "The EUR/USD pair loses momentum around 1.1120, snapping the three-day winning streak during the early European session on Wednesday. "

More news about USD/EUR (USDEUR).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com